Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 1.00 |
| ▸ | AKR1C3 | P42330 | 1/20 | 1.00 |
| ▸ | AKR1C2 | P52895 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | PTGER2 | P43116 | 11/20 | 0.39 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.37 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.32 |
| ▸ | PTGIR | P43119 | 2/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | PTGFR | P43088 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Jasmonic Acid SCHEMBL1365045 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL114054 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL7113180 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL125395 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL12216372 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL7113179 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL3074832 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL4360733 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL5598513 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL1365044 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025097009-A1 | ANTIBODIES AND IMMUNOCONJUGATES FOR INDIVIDUALIZED THERAPY | NANOCARE TECHNOLOGIES, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| CN-114641563-A | Compositions and methods for plant cell culture | 盖利公司 | 2022-06-17 | — | — | CN | claimed |
| EP-3973048-A1 | COMPOSITIONS AND METHODS FOR PLANT CELL CULTURE | Galy Co. (US) | 2022-03-30 | — | — | EP | claimed |
| US-20260117242-A1 | CELL LINES, VARIETIES, AND METHODS FOR IN VITRO COTTON FIBER PRODUCTION | GALY CO (US) | 2026-04-30 | — | — | US | disclosed |
| US-20250389055-A1 | VITRO LOW-TRASH COTTON FIBER PRODUCTION | GALY CO. (US) | 2025-12-25 | — | — | US | disclosed |
| US-12317796-B2 | Compositions and methods for cotton cell culture | GALY CO. (US) | 2025-06-03 | — | — | US | disclosed |
| CN-119979397-A | Siamese bacillus DG-39, microbial inoculum and application thereof in inhibiting early bolting of Chinese angelica | 甘肃省科学院生物研究所 | 2025-05-13 | — | — | CN | disclosed |
| CN-119286911-B | Salt-loving iris IhCHS gene for improving accumulation capacity of plant salt tolerance and jasmonate and application | 江苏省中国科学院植物研究所 | 2025-05-09 | — | — | CN | disclosed |
| WO-2025097009-A1 | ANTIBODIES AND IMMUNOCONJUGATES FOR INDIVIDUALIZED THERAPY | NANOCARE TECHNOLOGIES, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-119286911-A | Salt-loving iris IhCHS gene for improving accumulation capacity of plant salt tolerance and jasmonate and application | 江苏省中国科学院植物研究所 | 2025-01-10 | — | — | CN | disclosed |
| US-20250000127-A1 | PREPARATION OF DRIED PLANT MATERIAL HAVING AN INCREASED CONTENT OF PHYLLODULCIN | SYMRISE AG (DE) | 2025-01-02 | — | — | US | disclosed |
| US-20220272990-A1 | Methods and Compositions of the Botanical Extract to Promote and Boost Plant Growth and Prevent and Suppress Plant Diseases | PRODUITS BIO SUN INC (CA) | 2022-09-01 | — | — | US | disclosed |
| WO-2022155456-A1 | CELL LINES, VARIETIES, AND METHODS FOR IN VITRO COTTON FIBER PRODUCTION | GALY CO. (US) | 2022-07-21 | — | — | WO | disclosed |
| CN-114760844-A | Method for promoting and enhancing plant growth and preventing and inhibiting plant diseases and composition of plant extract | 有机防晒用品公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-114641563-A | Compositions and methods for plant cell culture | 盖利公司 | 2022-06-17 | — | — | CN | disclosed |
| EP-4003022-A1 | METHODS AND COMPOSITIONS OF A BOTANICAL EXTRACT TO PROMOTE AND BOOST PLANT GROWTH AND PREVENT AND SUPPRESS PLANT DISEASES | PRODUITS BIO SUN INC. (CA) | 2022-06-01 | — | — | EP | disclosed |
| WO-2022093785-A1 | CELL LINES, VARIETIES, AND METHODS FOR IN VITRO COTTON FIBER PRODUCTION | GALY CO. (US) | 2022-05-05 | — | — | WO | disclosed |
| EP-3973048-A1 | COMPOSITIONS AND METHODS FOR PLANT CELL CULTURE | Galy Co. (US) | 2022-03-30 | — | — | EP | disclosed |
| US-20040185075-A1 | Use of at least one (dihydro)jasmonic acid derivative for treating dry skin | L'OREAL S.A. (FR) | 2004-09-23 | — | — | US | disclosed |
| US-20030224024-A1 | Compositions comprising cyclopentane derivatives and their use | L'OREAL S.A. (FR) | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117242-A1 | CELL LINES, VARIETIES, AND METHODS FOR IN VITRO COTTON FIBER PRODUCTION | GTF2I, COLGALT1, CRY2 | AKR1C4 4675/4885AKR1C3 4719/4885AKR1C2 4438/4885 |
| US-20030224024-A1 | Compositions comprising cyclopentane derivatives and their use | CBR1, CBR3, DECR1 | AKR1C4 34/4885AKR1C3 23/4885AKR1C2 71/4885 |
| US-20040185075-A1 | Use of at least one (dihydro)jasmonic acid derivative for treating dry skin | CUTA, ALOX15, ALOX15B | AKR1C4 1048/4885AKR1C3 890/4885AKR1C2 959/4885 |
| US-20220272990-A1 | Methods and Compositions of the Botanical Extract to Promote and Boost Plant Growth and Prevent and Suppress Plant Diseases | MYB, DBN1, ERH | AKR1C4 4326/4885AKR1C3 4393/4885AKR1C2 4361/4885 |
| US-20250389055-A1 | VITRO LOW-TRASH COTTON FIBER PRODUCTION | TELO2, CRY2, AGL | AKR1C4 4832/4885AKR1C3 4868/4885AKR1C2 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.